Tag: Nasdaq:GRCE

Grace Therapeutics Announces Third Fiscal Quarter 2025Financial Results, Provides Business Update

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical…

GlobeNews Wire GlobeNews Wire